Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enrique Conterno
Pharma
AZ, FibroGen clash on roxa's US path forward in CKD anemia
The companies couldn't reach an agreement on a clinical development plan for a U.S. refiling despite “significant discussions,” FibroGen's CEO said.
Angus Liu
May 10, 2022 8:05am
New FibroGen CEO cut post-Lilly 'vacation' for roxadustat
Jan 14, 2020 4:40pm
Lilly USA chief Enrique Conterno to bow out at year's end
Oct 23, 2019 11:10am
Lilly’s strong Q1 cushions FDA thumbs-down on 4-mg baricitinib
Apr 24, 2018 12:31pm
Bring on semaglutide, Lilly says. We’re ready
Feb 12, 2018 9:55am
Eli Lilly counts up 2300 early retirements in cost-cutting drive
Nov 9, 2017 11:50am
